Skip to content

A comparative study of radiofrequency ablation and cardia coarctation for gastroesophageal reflux disease

A comparative study of radiofrequency ablation and cardia coarctation for gastroesophageal reflux disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500096784
Enrollment
Unknown
Registered
2025-02-06
Start date
2025-02-10
Completion date
Unknown
Last updated
2025-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroesophageal reflux disease

Interventions

PECC group:Endoscopic cardiac constriction

Sponsors

Henan Provincial People's Hospita,medical
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age>=18 years old; 2. Those who have been diagnosed with GERD through symptoms and signs, 24-hour esophageal pH monitoring or gastroscopy; 3. Symptoms that have not been relieved significantly for more than 2 months after systematic internal medicine treatment or recurrence after remission; 4. Voluntarily participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Combined hiatal hernia with a length of >2cm; 2. Severe reflux esophagitis (Los Angeles grade C, D grade); 3. Patients with Barrett's esophagus or early-stage cancer confirmed by biopsy; 4. Those who have undergone surgical treatment such as gastric plication and have destroyed the normal physiological and anatomical structure; 5. Patients with severe dysphagia, esophageal motility, esophageal stricture, achalasia and other diseases; 6. Those with allergies or severe cardiopulmonary dysfunction who cannot receive endoscopic treatment or are unwilling to undergo endoscopic treatment; 7. Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
24h esophageal pH monitoring;Symptom score;Esophageal pressure measurement results;Gastroscopy presentation (RE Los Angeles grading);

Secondary

MeasureTime frame
Use of PPIs before and after surgery;Surgical costs;Surgical time;Post-operative hospitalisation days;Postoperative adverse reaction;Relapse rate;

Countries

China

Contacts

Public ContactDing hui

Henan Provincial People's Hospita,medical

dinghui76sy@163.com+86 371 65897750

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026